SUMMARY Forty-three consecutive patients with polymyalgia rheumatica were studied for serological markers of actual or previous hepatitis B virus infection. Signs of active virus replication, which include HBsAg supported by the presence of HBeAg and anti-HBc in high titres, were not found in any cases. Anti-HBs, a serological sign of previous hepatitis B virus exposure, was present in 16.8%. The prevalence of anti-HBs is strongly age-dependent in the normal population, and its prevalence in polymyalgia rheumatica was not significantly different from the incidence found in other hospital patients. No significantly raised incidence was found in any subgroups, including patients with or without giant cell arteritis treated or not treated with prednisone and patients with or without liver dysfunction. These results do not support the concept that current or previous hepatitis B virus infection plays any role in the pathogenesis of the majority of cases of polymyalgia rheumatica. We decided to look for these serological markers in PMR and the results of a search for HBsAg, HBsAb, HBcAb, HBeAg, and HBeAb in the first 43 patients are presented here.
Polymyalgia rheumatica (PMR) and giant cell arteritis are closely related diseases of unknown aetiology. During a search for a virus aetiology Bacon et al. found an increased incidence of hepatitis B virus antibody.' This may be an important finding, as some reports during the last few years have demonstrated a link between hepatitis B virus infection and later development of vasculitis (polyarteritis nodosa, essential cryoglobulinaemia). [2] [3] [4] However, the normal serological events in the course of hepatitis B virus infection are characterised by the occurrence of several antibodies and antigens, of which the e/anti e system are indicators of chronicity.5 6 We decided to look for these serological markers in PMR and the results of a search for HBsAg, HBsAb, HBcAb, HBeAg, and HBeAb in the first 43 patients are presented here.
Patients and methods
Forty-three consecutive patients were studied. Thirty-six showed classical symptoms of PMR: 14 and shows an excess prevalence in older age groups (Fig. 1) , the prevalence in polymyalgia rheumatica is similar to the incidence in other hospital patients.
This strange age-dependent distribution of antiHBs antibodies-which is probably a cohort phenomenon and found in most Scandinavian countriesstrongly influences the interpretation of previous reports, the data in which are not based on agecorrected control populations.
Our data show a prevalence rate twice as high in the untreated group as in the steriod treated, which may imply, as proposed by Bacon et al.,' that prednisone decreases the antibody titre effectively.
Our data do not disprove the evidence for hepatitis B virus association in some cases of PMR, but provide evidence that the advocacy of this virus as the major cause of PMR is greatly overstated. PMR as a syndrome may be a final common pathway for a variety of antigen-antibody complex interactions. 
